Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3400482
Max Phase: Preclinical
Molecular Formula: C16H13N3O3S
Molecular Weight: 327.37
Molecule Type: Small molecule
Associated Items:
ID: ALA3400482
Max Phase: Preclinical
Molecular Formula: C16H13N3O3S
Molecular Weight: 327.37
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCN(c1ccc2c(c1)OCO2)c1nc(=O)c2cccnc2s1
Standard InChI: InChI=1S/C16H13N3O3S/c1-2-19(10-5-6-12-13(8-10)22-9-21-12)16-18-14(20)11-4-3-7-17-15(11)23-16/h3-8H,2,9H2,1H3
Standard InChI Key: YQGZOEJHOSOQBZ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 327.37 | Molecular Weight (Monoisotopic): 327.0678 | AlogP: 2.94 | #Rotatable Bonds: 3 |
Polar Surface Area: 64.55 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 0.01 | CX LogP: 2.92 | CX LogD: 2.92 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.74 | Np Likeness Score: -1.19 |
1. Inami H, Shishikura J, Yasunaga T, Ohno K, Yamashita H, Kato K, Sakamoto S.. (2015) Synthesis, structure-activity relationships, and anticonvulsant activities of 2-amino-4H-pyrido[3,2-e][1,3]thiazin-4-one derivatives as orally active AMPA receptor antagonists., 23 (8): [PMID:25792143] [10.1016/j.bmc.2015.02.033] |
Source(1):